STOCK TITAN

Medixall Stock Price, News & Analysis

MDXL OTC

Welcome to our dedicated page for Medixall news (Ticker: MDXL), a resource for investors and traders seeking the latest updates and insights on Medixall stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Medixall's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Medixall's position in the market.

Rhea-AI Summary

Summary not available.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.92%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags
none
Rhea-AI Summary

MediXall Group Inc. (OTCQB: MDXL) announced the appointment of Scott Leavitt as a Consultant. With over 28 years in healthcare and insurance, Leavitt will guide strategic initiatives to drive business growth and enhance market share through the Health Karma™ platform. His expertise aims to improve health insurance outreach and consumer engagement. Leavitt's background includes leadership roles in health organizations and media contributions on healthcare topics. MediXall aims to revolutionize healthcare by enhancing communication and offering innovative consumer services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

MediXall Group Inc. (OTCQB: MDXL) has launched Telehealth solutions aimed at over 80 million uninsured and underinsured Americans. In partnership with MeMD, users can now access online medical consultations, prescriptions, and lab tests for common medical issues. This initiative addresses the growing demand for affordable healthcare, accentuated by COVID-19. To incentivize use, MediXall is offering one month of free virtual care visits. The company aims to improve healthcare accessibility while reducing costs for both consumers and employers.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

What is the current stock price of Medixall (MDXL)?

The current stock price of Medixall (MDXL) is $0.0001 as of October 21, 2025.

What is the market cap of Medixall (MDXL)?

The market cap of Medixall (MDXL) is approximately 801.0K.

MDXL Rankings

MDXL Stock Data

801.00k
187.57M
Health Information Services
Healthcare
Link
United States
Leesburg

MDXL RSS Feed